No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Bone Density Conservation Agents / therapeutic use
-
Carcinoma, Small Cell / drug therapy*
-
Carcinoma, Small Cell / secondary
-
Diphosphonates / therapeutic use*
-
Female
-
Humans
-
Hypercalcemia / chemically induced*
-
Hypercalcemia / drug therapy*
-
Imidazoles / therapeutic use*
-
Middle Aged
-
Treatment Outcome
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / pathology
-
Zoledronic Acid
Substances
-
Bone Density Conservation Agents
-
Diphosphonates
-
Imidazoles
-
Zoledronic Acid